share_log

HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $20 Price Target

HC Wainwright & Co. Reiterates Buy on ALX Oncology Holdings, Maintains $20 Price Target

HC Wainwright & Co.重申買入ALX Oncology Holdings,維持20美元的目標股價
Moomoo 24/7 ·  04/10 11:18

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and maintains $20 price target.

HC Wainwright & Co. 分析師Swayampakula Ramakanth重申ALX Oncology Holdings(納斯達克股票代碼:ALXO)的買入並維持20美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論